Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta to Get $15M from Monsanto in Gene Expression Deal

NEW YORK, Nov 28 –Rosetta Inpharmatics said Tuesday that it has entered a three-year deal to provide Monsanto with crop gene expression data.

The collaboration, which follows a pilot agreement between the two companies, is exclusive for the family of crops that includes corn, rice, and wheat.

Under terms of the agreement, Monsanto will pay Rosetta $15 million over a three-year period for the delivery of the data. Rosetta will also receive future payments, including royalties, as Monsanto develops and commercializes products, such as improved crops, as a result of the collaboration.

Among other activities, Rosetta will create a large database of gene expression profiles and will apply existing as well as newly developed computational tools to data analysis.

" By combining our sequence portfolio with Rosetta's expertise, we are creating a unique capability to further understand gene expression in crops," said Chris Burnley, vice president for genomics strategy and alliances at Monsanto in a statement.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.